Navigation Links
Unigene Provides 2012 Business Outlook
Date:1/9/2012

PTH therapies.  The most common adverse event in the oral PTH arm was abdominal pain.

The Company expects to present the full data from the Phase 2 study in a peer review journal and/or prestigious scientific congress over the course of 2012.

Oral Calcitonin Program with Tarsa Therapeutics Preparing for NDA Submission

In 2009, Unigene licensed its late-stage oral calcitonin formulation to Tarsa Therapeutics (Tarsa), a venture financed company founded exclusively to conduct Phase 3 clinical testing and prepare Unigene's proprietary oral calcitonin formulation for commercialization. Unigene owns a 20% equity position in Tarsa on a fully diluted basis, subject to liquidating preferences. The Company is also eligible to receive sales-related milestone payments and royalties on worldwide sales excluding China. 

On September 19, 2011, Unigene announced that Tarsa presented positive Phase 3 data from its ORACAL trial of OSTORA™ during the annual American Society for Bone and Mineral Research (ASBMR) 2011 meeting. The data demonstrated that OSTORA achieved all of the efficacy endpoints in the trial, indicated that the safety profile of OSTORA did not substantially differ from nasal calcitonin or placebo and that OSTORA also appeared to be significantly less immunogenic than nasal calcitonin spray.  Developed by Unigene and licensed to Tarsa, OSTORA™ is an oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

The ORACAL study was a Phase 3 multinational, randomized, double-blind, double-dummy, placebo-controlled trial of OSTORA™ compared to placebo and to commercially available, synthetic salmon calcitonin administered by nasal spray. The primary efficacy endpoint was the percentage change in lumbar spine bone mineral density (BMD) after one year of treatment. The trial enrolled 565 postmenopausal women with established osteoporosis in si
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
2. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
3. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
4. Unigene Reports Third Quarter 2011 Financial Results
5. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
6. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
7. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
8. VIVUS Provides Qnexa Regulatory Update
9. New Product Planning Excellence Services Program Provides Road Map for Clinical Development Success in the Pharmaceutical Industry
10. ViroPharma Provides 2012 Outlook
11. Cogmedix Provides High-Precision Subassembly for LensAR Revolutionary Refractive Laser
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), ... the development of brachytherapy devices and medical isotopes ... it has filed a de novo ... for marketing clearance for its patented Y-90 RadioGel(TM) ... Food, Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
(Date:12/24/2014)... , Dec. 23, 2014  The American Diabetes ... pressure target for people with diabetes and that ... high doses of statins, in keeping with recent ... by the American College of Cardiology (ACC) and ... in the most recent changes to the Association,s ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... , May 13 Pacific Bridge Medical, a leading Asia ... on May 26, 2010 at 11am EDT . , ... Taiwan is the sixth largest pharmaceutical market in the ... a solid national health care system. This webcast will give an overview of ...
... , SEATTLE , May 13 ... company, today announced that, based on successful preclinical studies, ... MASP-2 antibody program and has initiated the cGMP manufacturing ... have shown that Omeros, proprietary, fully human, monoclonal MASP-2 ...
Cached Medicine Technology:Pacific Bridge Medical to Host Taiwan Drug Registration Webinar 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 3Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 4
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- Adults who experienced ... of migraine headaches, suggests a study published online ... "Childhood maltreatment can have long-lasting effects, like ... adulthood," study author Dawn Buse, director of behavioral ... City, said in a journal news release. ...
(Date:12/24/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... start smoking or drinking with each additional symptom they ... new research suggests. "Our findings underscore the ... use as [these] children approach adolescence," said study author ... Group, which is part of Cincinnati Children,s Hospital. "This ...
(Date:12/24/2014)... Reinberg HealthDay Reporter TUESDAY, ... American Diabetes Association (ADA) call for giving the cholesterol-lowering drugs ... prevent heart disease. These new standards bring the association ... Heart Association, which also recommend giving low- or high-dose statins ... with diabetes. "We agree that the decision to start ...
(Date:12/24/2014)... For chic ladies, new fashionable outfits are necessary when ... Holiday Wish List, Angeldress.co.uk has chosen some of ... ladies’ holiday wardrobe by launching a promotion on its cheap ... discount of 80% off, like a cheap suit. , “All ... chic wedding dresses are among the hottest items in the ...
(Date:12/24/2014)... December 24, 2014 Dr. Svetlana Gomer, ... across the nation gathered with US Marines on November ... raise funds for the Toys for Tots Literacy Program. ... thousands of new books and audio books for the ... underprivileged children this Christmas. It represents another major strike ...
Breaking Medicine News(10 mins):Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3
... and MDS Pharma Services, Goodwill, , ... (TSX: MDS; NYSE: MDZ ), a leading provider of ... update for fiscal 2008 performance. , Based on preliminary ... the range of $1,210 million to $1,220 million and adjusted EBITDA ...
... Congress are determined to complete the job started around 1900 and ... They plan to move fast, seize momentum, and not let go. ... on the offense," said former South Dakota Senator Tom Daschle, presumptive ... , The bill might well be S. 1, and ...
... plc (NASDAQ:, ICLR )(ISIN:IE0005711209), a global ... biotechnology and medical device industries,today announced that ... new cardiac,echocardiography analysis software solution. The software, ... viewed, measured and interpreted,in clinical trials and ...
... spending hundreds of millions annually to prevent dry skin... much of the ... can be taken to heal and protect the skin. , ... Denver, ... of the year for scores of people across the country suffering from ...
... out of Wake Forest University School of Medicine and the ... popular class of oral diabetic drugs doubles the risk of ... findings appear online today on the Web site for the ... the January 6 issue. , "We knew going into this ...
... highlights from the December issue of Mayo Clinic Women,s HealthSource ... Mayo Clinic Women,s HealthSource attribution is ... subscription information as your editorial policies permit: Visit www.bookstore.mayoclinic.com ... , , Who,s ...
Cached Medicine News:Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Blitzkrieg Declared On American Medicine 2Health News:Blitzkrieg Declared On American Medicine 3Health News:ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software 2Health News:Top Tips To Naturally Heal Dry Skin And Moisturize This Winter 2Health News:Top Tips To Naturally Heal Dry Skin And Moisturize This Winter 3Health News:Popular class of diabetes drugs doubles risk of fractures in women 2Health News:Popular class of diabetes drugs doubles risk of fractures in women 3Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 2Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 3Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 4Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 5
... The SkanWasher 400 is ... microplate washer with built-in ... The individual pressure settings ... very gentle wash to ...
Lab-Reader...
Fully automatic NRTL and CE certified microplate reader....
... a compact and versatile multilabel ... design allows up to six ... counting, luminescence, absorbance, and fluorescence ... and fluorescence polarization all on ...
Medicine Products: